The U. S. Food and Drug Administration (FDA) approved the emergency authorization requested by the pharmaceutical companies Moderna, and Pfizer- BioNTech to distribute their reformulated versions of the COVID — 19 vaccines to be distributed in September 2022. It is estimated that delaying the roll-out of the vaccines till November of this year would result in more than100,000 additional hospitalizations and in thousands of additional deaths.